1. Inhaled hypertonic saline in infants and children younger than 6years with cystic fibrosis: the ISIS randomized controlled trial;Rosenfeld;JAMA,2012
2. Clinical trial outcome assessments: identifying intrinsic characteristics;Walton,2011
3. The Pre-School Cystic Fibrosis Questionnaire-Revised: initial validation results;Quittner,2011
4. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims;United States Food and Drug Administration,2009
5. Guidance for industry: Qualification process for drug development tools;United States Food and Drug Administration,2010